GLP-1s Could Help Curb Substance Use Disorders

Emerging research suggests GLP-1 medications, such as semaglutide and tirzepatide, may help reduce use of alcohol, opioids, nicotine, and other substances. A recent study analyzed records from over 600,000 adults with Type 2 diabetes, finding fewer hospitalizations, emergency visits, and deaths among those using GLP-1s compared with other diabetes drugs.

While most prior research focused on alcohol use disorder, these findings point to broader potential effects on multiple substance use disorders and possibly prevention. Researchers note further randomized trials are needed, but GLP-1s may represent a promising tool in addressing substance use from a public health perspective. Read more from NBC News here.